New urine test for early breast cancer detection in Aberystwyth

Scientists in Aberystwyth are creating a new urine test for breast cancer. This test could find the disease earlier than current methods, potentially saving lives.
By Newsroom | Health, Science |

Aberystwyth University researchers are working on a urine test, akin to those used for Covid-19 or pregnancy, which they say could identify early-stage breast cancer. The approach hinges on detecting metabolic shifts within the body that correlate with the disease's presence.

This investigative pathway aims to pinpoint cancer before outward indicators manifest. The development arrives against a backdrop where breast cancer is the most prevalent cancer among females, with the UK alone recording over 56,000 diagnoses annually. Survival rates for advanced-stage cancer remain stark; just one in four women with stage four breast cancer live beyond five years.

Covid-style at-home test could detect breast cancer before symptoms begin - 1

A Test of Metabolic Signatures

The scientists at Aberystwyth University have identified particular metabolic alterations tied to breast cancer. Their goal is to translate these findings into a practical, user-friendly test format. This lateral flow device, familiar to many from recent public health measures, would analyze a single urine sample for these specific markers.

Read More: Australia May End Cervical Cancer by 2035, But Some Groups Need More Help

Contextualizing Early Detection

The push for earlier detection methods is underscored by the outcomes of delayed diagnosis. The report notes that survival chances diminish significantly as the disease progresses, highlighting the potential value of a pre-symptomatic diagnostic tool.

A Broader Trend in Diagnostic Technology

This development echoes similar advancements in disease detection. Notably, a Covid-style swab test has also been introduced for womb cancer. This test, employing comparable technology, is intended to provide a less invasive means of diagnosing the disease compared to traditional methods like scans or hysteroscopies. For womb cancer, which affects nearly 10,000 British women each year, symptoms such as post-menopausal bleeding, unusually heavy periods, or changes in discharge previously necessitated more involved examinations. This new testing strategy has also reportedly reduced false positive rates.

Frequently Asked Questions

Q: What is Aberystwyth University researching?
Researchers at Aberystwyth University are developing a new urine test. This test aims to find breast cancer early, before any signs appear, similar to Covid or pregnancy tests.
Q: How will the new breast cancer urine test work?
The test will look for small changes in the body's chemistry (metabolic shifts) in a urine sample. These changes are linked to breast cancer, helping to detect it early.
Q: Why is an early breast cancer test important?
Finding breast cancer early greatly increases survival chances. Currently, only one in four women with stage four breast cancer live longer than five years, showing the need for faster detection.
Q: Is this new test available now?
This is still a research project by Aberystwyth University. It is not yet available to the public, but scientists hope it will become a simple, user-friendly test in the future.
Q: Are there similar new tests for other cancers?
Yes, similar technology is being used for a new test for womb cancer in the UK. This test also aims for easier and earlier detection compared to older methods.